Autonomix Medical (NASDAQ:AMIX) announced that the Society of Interventional Radiology (SIR) has accepted its abstract highlighting its technology and early proof-of-concept study results for a poster presentation at the 2025 annual meeting, taking place from March 29 to April 2 in Nashville.
According to the company, the abstract, titled Pain Mitigation in Pancreatic Adenocarcinoma: An Interim Analysis of Neurolysis via Transvascular RF Energy-Based Ablation, will be presented by Bela Kis, MD, PhD, FSIR, chief of interventional radiology, at Moffitt Cancer Center, on Monday, March 3, at 12:10 PM CT.
